The Bill & Melinda Gates Foundation is a grant-making foundation that supports initiatives in education, world health and population, and community giving in the Pacific Northwest. In its local region, the foundation promotes strategies and programs that help low-income families. The Bill & Melinda Gates Foundation was co-founded by Bill Gates and Melinda Gates in 2000 and is based in Seattle, Washington, with regional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. Its trustees are Bill and Melinda Gates, and Warren Buffett.

Bloomlife is an award-winning women’s health company solving the most significant yet underserved global challenges today in maternal health. We are redefining the way prenatal care is delivered by combining connected devices with cloud-based data analytics to improve access to care, empower women, and provide clinicians with information to more effectively screen and manage pregnancy complications. Our goal is to become the leading provider of remote care for expectant women globally. Bloomlife’s approach to managing high-risk pregnancies allows obstetricians to more easily screen maternal and fetal risk, educate the patient, and quickly access high-risk specialists regardless of a patient’s geography. Our solution represents a marked shift from the way high-risk pregnancies have been historically assessed using frequent in-person appointments, paper logs, and long referral times.

Carrot Fertility is a fertility treatment center that provides financial and medical services for employees. Their program includes egg freezing, in vitro fertilization, donor, gestational carrier services, adoption, and pregnancy. They help people through fertility preservation, male-factor infertility, postpartum, gestational surrogacy, and menopause.

Delfina provides a personalized prenatal care system that uses the power of data to keep moms and babies safe during pregnancy. Their data-driven approach is uncovering unique insights in prenatal care to pave the way for clinical innovation.

Diana Health offers personalized women's healthcare services in maternity, gynecology, menopause, mental health, and wellness. It supports women at various life stages, from new to women’s health, through pregnancy and menopause, by addressing both everyday health needs and more complex concerns like abnormal bleeding, PCOS, pelvic pain, and sexual or urinary issues. Care is tailored through collaborative care teams that include OB/GYNs, Certified Nurse Midwives, and Nurse Practitioners, depending on the patient’s preferences and medical needs. Diana Health integrates physical, social, and emotional health into each care plan, using digital tools, longer appointments, and educational resources to make the care experience more personal.

Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. We transform complex biomarker data into life-changing insights, seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens. Over the past decade, Everlywell has delivered close to 1 billion personalized health insights, transforming care for 60 million people and powering hundreds of enterprise partners including 8 of the top 10 largest health plans in the U.S. From chronic condition management to preventive screening, our customizable remote-based solution helps close critical care gaps and deliver measurable health outcomes at scale. Backed by a nationwide clinical network, integrated lab, and AI-powered platform, Everlywell enables seamless, at-home care that meets today's needs and leads the way into tomorrow's healthcare.

At FLO, our purpose is to build a better future for female health by helping you harness the power of your body signals. FLO is the #1 downloaded women’s health app worldwide, with 380 million downloads and 70 million monthly active users. Close to 60% of monthly active users rely on FLO for over a year. In the US, 1 in 4 women (ages 18-44) use FLO. FLO is also the first purely digital consumer women’s health app to achieve unicorn status and have a valuation beyond $1 billion. With over 120+ medical experts, FLO is committed to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. It provides curated cycle and ovulation tracking, tailored health insights, daily bite-sized visual content, and a private community for users to share their questions and concerns. FLO prioritizes safety and is focused on being the most trusted digital source for women's health information. Its anonymous mode feature was recognized as one of TIME’s Best Inventions 2023 and also named a finalist for Fast Company’s 2023 World Changing Ideas Awards in the Rapid Response category. FLO tackles several key issues: - Bridging healthcare disparities: FLO provides free premium access to up to 1 billion women in 66 countries, with 17 million subscriptions donated. FLO is working with UNFPA to level the playing field in women's health. - Closing the knowledge gap: By providing accurate, accessible information to millions, FLO is improving health literacy on a global scale. - Driving research and innovation: With partnerships with world-class institutions, FLO is uniquely positioned to advance women's health research and drive evidence-based improvements in care. - Breaking taboos: FLO is normalizing conversations around women's health, helping to reduce stigma and encourage open dialogue. - Empowering through health information: FLO is putting personalized insights directly into users’ hands, fostering proactive health management.

Frida is more than a brand built to support parents. We get parents. We know all about the often unbelievable realities of parenthood because we’ve been in the trenches. Over the last 9 years, we’ve dedicated ourselves to developing the tools (and sometimes the tips, too) that help simplify parenting - and it all started with snot. Since the launch of our cult-favorite NoseFrida, the snot sucker, we’ve innovated and launched over 100 products that provide quick and easy solutions to age-old parenting problems. We also launched Frida Mom in 2019, with products to help women with the transition through the fourth trimester into motherhood. Today, Frida holds over a 70% share of its main category, and our products can be found in over 50 countries and in over 40,000 stores throughout the U.S. - in every retail channel from mass-market, grocery, chain drug, and specialty stores. For 7 years, we’ve had parents’ backs as they navigate the parts of parenthood you don’t usually see on the ’gram with honest and raw messaging to provide the answers to questions they didn’t even know they had. And, we’re just getting started.

Gaia combines reproductive health data with financial technology to make IVF treatments more accessible, affordable, and personal.

Herself Health provides person-centered, value-based care to women 65+ with a focus on mind, body, and soul. This holistic approach to care delivery aims to improve the quality of life of both the women for whom we care and the clinical team of physicians, nurses, and medical assistants. We realize that health is more than just healthcare, and our goal is to help each Herself woman live her best life.

Hers is a wellness brand that helps women get access to products for skin care, hair loss, and sexual health.

Maven Clinic operates an on-demand digital care clinic that assists mothers and families during conception, throughout pregnancy, and postpartum. It offers video appointments and private messaging with its proprietary women's and family health practitioner network, as well as a family benefits platform. Maven Clinic offers its services for IVF and egg-freezing tracks, pregnancy, postpartum, partner, adoption, surrogacy, and loss tracks, and career coaching and support, and customized manager training for HR. It serves individuals, employers, and healthcare professionals. It was founded in 2014 by Katherine Ryder and is headquartered in New York City.